Interleukin-33 improves the neurogenesis of neural stem cells in perinatal brain after hypoxia–ischemia
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.110778 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Jing Tian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangdong Provincial Key Laboratory of Pharm…. Hauptthemen laut MEDLINE: Neural Stem Cells, Hypoxia-Ischemia, Brain. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
Perinatal hypoxia-ischemia (HI) insult is an important cause of neonatal encephalopathy, and the effective therapeutic approaches are currently limited. Interleukin (IL)-33 acts as a member of the IL-1 superfamily and has been shown to be neuroprotective following experimental neonatal HI and adult stroke. Here, we explore the effect of IL-33 and its specific receptor ST2 axis on endogenous neurogenesis in neonatal brain after HI. ST2 was found on the surface of NSCs, and the expression of ST2 was further enhanced after HI challenge. Delivery of IL-33 obviously repopulated the size of NSC pool, whereas ST2 deficiency worsened the neurogenesis of NSCs in neonatal brain post HI insult. Further in vivo and in vitro studies showed IL-33 regulates the survival, proliferation and differentiation of NSCs through ST2 signaling pathways. Intriguingly, IL-33 facilitated translocation of Nrf2 from the cytoplasm to the nucleus, which is involved in neural differentiation of NSCs. These data demonstrate a critical role of IL-33/ST2 axis in regulation of endogenous neurogenesis of NSCs via activation of the Nrf2 signaling, which provide a new insight into the effect of IL-33 in neonatal brain following HI injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, Guangdong Pharmaceutical University, G…
- School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
- Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, Guangdong Pharmaceutical University, Guangzhou 510006, China.
- School of Food Science, Guangdong Pharmaceutical University, Zhongshan 528453, China.
- Department of Pediatrics, Longgang District Maternity & Child Healthcare Hospital of Shenzhen City, Shenzhen 518172, China.
- Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, Guangdong Pharmaceutical University, Guangzhou 510006, China. Electronic address: tliu@foxmail.com.
Zitieren
APA
Tian, J., Zhu, J., Fan, Q., Luo, X., Nie, Q., Yu, J., Wu, X., Tang, Y., Liu, T., & Yin, H. (2023). Interleukin-33 improves the neurogenesis of neural stem cells in perinatal brain after hypoxia–ischemia. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110778
Vancouver
Tian J, Zhu J, Fan Q, Luo X, Nie Q, Yu J, et al. Interleukin-33 improves the neurogenesis of neural stem cells in perinatal brain after hypoxia–ischemia. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110778
BibTeX
@article{Tian2023,
author = {Tian, Jing and Zhu, Jieqiong and Fan, Qiuxiang and Luo, Xiaotian and Nie, Qianying and Yu, Jingwei and Wu, Xiaoyong and Tang, Yanli and Liu, Tao and Yin, Hui},
title = {Interleukin-33 improves the neurogenesis of neural stem cells in perinatal brain after hypoxia–ischemia},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.110778}
}
EUVIMED